首页> 外文期刊>Quimica nova >Simultaneous determination of olanzapine and fluoxetine hydrochloride in pharmaceutical formulations by derivative spectrophotometry
【24h】

Simultaneous determination of olanzapine and fluoxetine hydrochloride in pharmaceutical formulations by derivative spectrophotometry

机译:导数分光光度法同时测定药物制剂中的奥氮平和盐酸氟西汀

获取原文
获取原文并翻译 | 示例
           

摘要

Simple, sensitive and accurate spectrophotometric derivative methods were developed for the simultaneous determination of olanzapine and fluoxetine hydrochloride in pharmaceutical formulations by derivative spectrophotometry. On all orders of derivative studied, the linear response range was 10 to 60 mg L ~(-1), with limit of quantitation(LoQ)ranging from 0.73 to 1.49 mg L ~(-1)for fluoxetine hydrochloride and from 0.18 to 0.96 mg L ~(-1)for olanzapine. The best orders for derivative analyses showed recoveries ranging from 99 to 103% and from 98 to 100%, and inter-day accuracy ≤ 2.1% and ≤ 2.8%, for fluoxetine hydrochloride and olanzapine, respectively.
机译:开发了一种简单,灵敏,准确的分光光度法导数方法,通过导数分光光度法同时测定药物制剂中的奥氮平和盐酸氟西汀。在研究的所有阶数的衍生物上,线性响应范围为10至60 mg L〜(-1),对于氟西汀盐酸盐的定量极限(LoQ)为0.73至1.49 mg L〜(-1),0.18至0.96奥氮平的mg L〜(-1)。衍生分析的最佳顺序表明,盐酸氟西汀和奥氮平的回收率分别为99%至103%和98%至100%,日间准确度分别≤2.1%和≤2.8%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号